OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression
Mark J. Wall, Emily Hill, Robert Huckstepp, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 340-372
Open Access | Times Cited: 109

Ligand and G-protein selectivity in the κ-opioid receptor
Jianming Han, Jingying Zhang, Antonina L. Nazarova, et al.
Nature (2023) Vol. 617, Iss. 7960, pp. 417-425
Open Access | Times Cited: 44

Direct interrogation of context-dependent GPCR activity with a universal biosensor platform
Remi Janicot, Marcin Maziarz, Jong‐Chan Park, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1527-1546.e25
Open Access | Times Cited: 21

GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4

Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3

A community Biased Signaling Atlas
Jimmy Caroli, Alibek Mamyrbekov, Kasper Harpsøe, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 5, pp. 531-535
Closed Access | Times Cited: 25

Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition
Terry Kenakin
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 626-644
Closed Access | Times Cited: 8

IUPHAR themed review: Opioid efficacy, bias, and selectivity
Nokomis Ramos‐Gonzalez, Barnali Paul, Susruta Majumdar
Pharmacological Research (2023) Vol. 197, pp. 106961-106961
Open Access | Times Cited: 18

New paradigms in purinergic receptor ligand discovery
Kenneth A. Jacobson, Balaram Pradhan, Zhiwei Wen, et al.
Neuropharmacology (2023) Vol. 230, pp. 109503-109503
Open Access | Times Cited: 17

Pharmacology of Adenosine Receptors: Recent Advancements
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1387-1387
Open Access | Times Cited: 17

Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
Supriya A. Gaitonde, Charlotte Avet, Mario de la Fuente Revenga, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2753-2764
Open Access | Times Cited: 6

Novel Therapeutic Targets for Migraine
Areeba Nisar, Zubair Ahmed, Hsiangkuo Yuan
Biomedicines (2023) Vol. 11, Iss. 2, pp. 569-569
Open Access | Times Cited: 14

Ligand-Directed Labeling of the Adenosine A1 Receptor in Living Cells
Eleonora Comeo, Joëlle Goulding, Chia-Yang Lin, et al.
Journal of Medicinal Chemistry (2024)
Open Access | Times Cited: 5

The full activation mechanism of the adenosine A 1 receptor revealed by GaMD and Su-GaMD simulations
Yang Li, Jixue Sun, Dongmei Li, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 42
Open Access | Times Cited: 20

Species dependence of A3 adenosine receptor pharmacology and function
Zhan‐Guo Gao, John A. Auchampach, Kenneth A. Jacobson
Purinergic Signalling (2022) Vol. 19, Iss. 3, pp. 523-550
Open Access | Times Cited: 19

Attributes novel drug candidate: Constitutive GPCR signal bias mediated by purinergic receptors
Li Yin, Kexin Ni, Tianqi Mao, et al.
Pharmacology & Therapeutics (2025), pp. 108802-108802
Closed Access

Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Giuseppe Deganutti, Ludovico Pipitò, Roxana‐Maria Rujan, et al.
eLife (2025) Vol. 13
Open Access

Minute-timescale free-energy calculations reveal a pseudo-active state in the adenosine A2A receptor activation mechanism
Vincenzo Maria D’Amore, Paolo Conflitti, Luciana Marinelli, et al.
Chem (2024) Vol. 10, Iss. 12, pp. 3678-3698
Open Access | Times Cited: 3

Progress on the development of Class A GPCR‐biased ligands
Paula Morales, Magdalena M. Scharf, Marcel Bermúdez, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3

Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Giuseppe Deganutti, Ludovico Pipitò, Roxana M. Rujan, et al.
(2024)
Open Access | Times Cited: 2

Molecular Simulations and Drug Discovery of Adenosine Receptors
Jinan Wang, Apurba Bhattarai, N. Hung, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2054-2054
Open Access | Times Cited: 11

Targeting corticostriatal transmission for the treatment of cannabinoid use disorder
Sergi Ferré, Attila Köfalvi, Francisco Ciruela, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 8, pp. 495-506
Open Access | Times Cited: 5

Potent and Selective Human 5-HT2B Serotonin Receptor Antagonists: 4′-Cyano-(N)-methanocarba-adenosines by Synthetic Serendipity
Dilip K. Tosh, Matteo Pavan, A. Clark, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top